Brandon Couillard
Stock Analyst at Wells Fargo
(4.39)
# 261
Out of 4,818 analysts
119
Total ratings
56.63%
Success rate
14.31%
Average return
Main Sectors:
Stocks Rated by Brandon Couillard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMO Thermo Fisher Scientific | Maintains: Overweight | $580 → $570 | $426.66 | +33.60% | 5 | Apr 24, 2025 | |
| A Agilent Technologies | Maintains: Hold | $135 → $116 | $107.02 | +8.39% | 22 | Apr 21, 2025 | |
| RVTY Revvity | Maintains: Equal-Weight | $130 → $102 | $95.13 | +7.22% | 2 | Apr 17, 2025 | |
| MTD Mettler-Toledo International | Maintains: Equal-Weight | $1,400 → $1,125 | $1,075.00 | +4.65% | 4 | Apr 17, 2025 | |
| BRKR Bruker | Maintains: Overweight | $75 → $60 | $38.97 | +53.96% | 3 | Apr 17, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Equal-Weight | $320 → $270 | $249.74 | +8.11% | 9 | Apr 17, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Equal-Weight | $320 → $270 | $234.41 | +15.18% | 9 | Apr 17, 2025 | |
| AVTR Avantor | Maintains: Overweight | $25 → $22 | $15.50 | +41.94% | 4 | Apr 17, 2025 | |
| WAT Waters | Maintains: Overweight | $415 → $420 | $340.70 | +23.28% | 3 | Feb 13, 2025 | |
| DHR Danaher | Maintains: Equal-Weight | $280 → $240 | $196.50 | +22.14% | 2 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $260 | $184.27 | +41.10% | 11 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $77 → $80 | $66.23 | +20.79% | 6 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $28 → $24 | $18.49 | +29.80% | 2 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $85 | $45.60 | +86.40% | 16 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $34 → $75 | $109.39 | -31.44% | 2 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $35 | $7.37 | +374.90% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $180 | $145.23 | +23.94% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $10 | $2.07 | +383.09% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $120 | $116.32 | +3.16% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $30 → $23 | $15.98 | +43.93% | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $0.71 | +1,723.28% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.03 | - | 11 | Nov 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $2.30 | +378.26% | 2 | Oct 13, 2017 |
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Overweight
Price Target: $580 → $570
Current: $426.66
Upside: +33.60%
Agilent Technologies
Apr 21, 2025
Maintains: Hold
Price Target: $135 → $116
Current: $107.02
Upside: +8.39%
Revvity
Apr 17, 2025
Maintains: Equal-Weight
Price Target: $130 → $102
Current: $95.13
Upside: +7.22%
Mettler-Toledo International
Apr 17, 2025
Maintains: Equal-Weight
Price Target: $1,400 → $1,125
Current: $1,075.00
Upside: +4.65%
Bruker
Apr 17, 2025
Maintains: Overweight
Price Target: $75 → $60
Current: $38.97
Upside: +53.96%
Bio-Rad Laboratories
Apr 17, 2025
Maintains: Equal-Weight
Price Target: $320 → $270
Current: $249.74
Upside: +8.11%
Bio-Rad Laboratories
Apr 17, 2025
Maintains: Equal-Weight
Price Target: $320 → $270
Current: $234.41
Upside: +15.18%
Avantor
Apr 17, 2025
Maintains: Overweight
Price Target: $25 → $22
Current: $15.50
Upside: +41.94%
Waters
Feb 13, 2025
Maintains: Overweight
Price Target: $415 → $420
Current: $340.70
Upside: +23.28%
Danaher
Jan 30, 2025
Maintains: Equal-Weight
Price Target: $280 → $240
Current: $196.50
Upside: +22.14%
Jan 23, 2025
Maintains: Buy
Price Target: $285 → $260
Current: $184.27
Upside: +41.10%
Jan 23, 2025
Maintains: Hold
Price Target: $77 → $80
Current: $66.23
Upside: +20.79%
Jan 15, 2025
Upgrades: Equal-Weight
Price Target: $28 → $24
Current: $18.49
Upside: +29.80%
Nov 6, 2024
Maintains: Buy
Price Target: $84 → $85
Current: $45.60
Upside: +86.40%
Oct 30, 2024
Maintains: Equal-Weight
Price Target: $34 → $75
Current: $109.39
Upside: -31.44%
Aug 27, 2024
Initiates: Overweight
Price Target: $35
Current: $7.37
Upside: +374.90%
Aug 27, 2024
Initiates: Overweight
Price Target: $180
Current: $145.23
Upside: +23.94%
Aug 27, 2024
Initiates: Overweight
Price Target: $10
Current: $2.07
Upside: +383.09%
Aug 27, 2024
Initiates: Underweight
Price Target: $120
Current: $116.32
Upside: +3.16%
Feb 9, 2024
Downgrades: Hold
Price Target: $30 → $23
Current: $15.98
Upside: +43.93%
Jul 13, 2021
Initiates: Buy
Price Target: $13
Current: $0.71
Upside: +1,723.28%
Nov 2, 2017
Downgrades: Hold
Price Target: n/a
Current: $3.03
Upside: -
Oct 13, 2017
Maintains: Buy
Price Target: $9 → $11
Current: $2.30
Upside: +378.26%